Roni Shouval

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  

Roni Shouval
Dec 11, 2024, 14:53 | Insight
Five articles suggested by Yan Leyfman
Yan Leyfman MD is the Co-founder and executive director of MedNews Week. He is also the…
Nov 28, 2024, 16:34 | Blog
Roni Shouval: Insights into Renal Injury in CAR-T Therapy from Global FDA Reports
Roni Shouval , Assistant Attending Adult BMT and Cellular Therapy Service at MSKCC, shared on…
Oct 18, 2024, 16:08 | Insight
Brandon Imber: Effective cytoreduction improves outcomes for CAR T cell patients
Brandon Imber, Radiation Oncologist at Memorial Sloan Kettering Cancer Center, posted the following on X: “Effective…
Sep 22, 2024, 04:52 | Blog
Rahul Banerjee: Why CAR-T recipients may appear to be at increased SPM risk?
Rahul Banerjee shared a post by The Cancer Letter on X, adding: "Thanks The Cancer Letter for the…
Sep 14, 2024, 17:46 | Insight
Kai Rejeski: Second Primary Malignancies following CAR T-cell therapy
Kai Rejeski shared a post on X about a recent paper by Tobias Tix et…
Sep 11, 2024, 09:23 | Insight
Myeloma Paper of the Day, September 11th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Systematic review and meta-analysis of…
Jul 24, 2024, 08:12 | Insight
Meta-analysis of non-relapse mortality post-CAR-T cells in lymphoma and myeloma
Nature Medicine shared on X about a paper titled "A systematic review and meta-analysis of nonrelapse…
Jul 14, 2024, 01:25 | Insight
Piotr Wysocki: Nonrelapse mortality in CAR-T-treated patients. Beware of infections!
Piotr Wysocki recently posted on LinkedIn: "Cordas DM et al. conducted a systematic review and meta-analysis…
Jul 12, 2024, 19:08 | Insight
Interesting study - A meta-analysis of nonrelapse mortality after CAR T cell therapy
Vivek Subbiah shared on X: "Interesting study published in NatureMedicine: A systematic review and meta-analysis…
Jul 9, 2024, 06:46 | Blog
David Cordas dos Santos: Nonrelapse mortality after CAR-T cell treatment
David Cordas dos Santos, PostDoc at Dana-Farber Cancer Institute, made the following post on X:…
Jul 8, 2024, 17:31 | Insight
Kai Rejeski: Underestimated aspect of CAR T-cell therapy: non-relapse mortality
Kai Rejeski, Visiting investigator at Memorial Sloan Kettering Cancer Center, shared on X: “Hot off…
Apr 26, 2024, 20:41 | Insight
Piotr Wysocki: CAR-T therapy seems to be associated with second primary malignant neoplasms
Piotr Wysocki recently shared on LinkedIn: "In a research letter published online in JAMA Oncology,…
Apr 21, 2024, 18:22 | Blog
Vivek Subbiah: Pleased to host a podcast interview with Roni Shouval on Secondary T-Cell Malignancies Following CAR T-Cell Therapy
Vivek Subbiah shared a post on X: “Secondary T-Cell Malignancies Following Chimeric antigen receptor (CAR) T-Cell…
Dec 21, 2023, 10:30 | Blog
MSKCC experts presented research related to managing and reducing treatment-related toxicities at the ASH - Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center shared on LinkedIn: ''Memorial Sloan Kettering Cancer Center (MSK) experts,…
All: 14 Posts: 1 - 100
Special Coverage